Spending my Saturday morning, as I do, trolling through published U.S. Patent Applications so as to help out a consultant friend and make a few bucks in the process, I came across this one:
United States Patent Application 20050069541
Karlik, Stephen J. ; et al.
March 31, 2005
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents.
Which I didn't find so terribly interesting (you'll be shocked to hear), until I came across this particular claim:
16. The method of claim 15, wherein the effective blood level of natalizumab is about 1 gnome.
Hm. I always suspected that gnomes were useful for something.